Brain

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets…

1 year ago

Unlock the “Craving Reset Code” and Break Free from Nicotine Addiction – The Revolutionary Holistic Approach to Quitting for Good

Revolutionary "Craving Reset Code" empowers individuals to lead a healthier, smoke-free life. SAN FRANCISCO, CA / ACCESSWIRE / September 4,…

1 year ago

Subtle Medical Awarded Phase II Funding for SBIR Grant to Expand SubtleSYNTH™ Technology to Brain Imaging

The news comes on the heels of SubtleSYNTH receiving FDA clearance of SubtleSYNTH™ for Spine STIRs MENLO PARK, Calif., Sept. 4, 2024…

1 year ago

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the…

1 year ago

NovaSight Announces Publication of Study Showing CureSight’s Superiority Over Patching

Patients Using the CureSight Digital Eye-Tracking Device for Amblyopia Treatment Achieved Significantly Greater Visual Acuity Gains in Per-Protocol AnalysisAIRPORT CITY,…

1 year ago

IRLAB is Granted Additional Patent for Drug Candidate Mesdopetam that Expands its Patent Protection

GOTHENBURG, SWEDEN / ACCESSWIRE / September 4, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 4, 2024 - IRLAB Therapeutics…

1 year ago

Revolutionary Hypnotherapy Technique Emerges as the #1 Method to Quit Nicotine – Changing the Game in Behavioral Health

SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2024 / In a groundbreaking development for those struggling with nicotine addiction,…

1 year ago

EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations

Support from the Brain Tumor Investment Fund, a subsidiary of the National Brain Tumor Society, and Sontag Innovation Fund Strengthens…

1 year ago

Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health

The investment is a pivotal milestone allowing Segmed to further expand its medical imaging solutions for artificial intelligence development and…

1 year ago

Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H

SAN DIEGO, Sept. 3, 2024 /PRNewswire/ -- Cortechs.ai, the leader in volumetric neuroimaging analysis, announces FDA 510(k) clearance for its NeuroQuant®…

1 year ago